The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.
Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability
Open accessAbstract
Genetic evidence predicts a causative role for amyloid-beta (A beta) in Alzheimer's disease. Recent debate has focused on whether fibrils (amyloid) or soluble oligomers of A beta are the active species that contribute to neurodegeneration and dementia. We developed two aggregation protocols for the consistent production of stable oligomeric or fibrillar preparations of A beta-(1-42). Here we report that oligomers inhibit neuronal viability 10-fold more than fibrils and approximately 40-fold more than unaggregated peptide, with oligomeric A beta-(1-42)-induced inhibition significant at 10 nm. Under A beta-(1-42) oligomer- and fibril-forming conditions, A beta-(1-40) remains predominantly as unassembled monomer and had significantly less effect on neuronal viability than preparations of A beta-(1-42). We applied the aggregation protocols developed for wild type A beta-(1-42) to A beta-(1-42) with the Dutch (E22Q) or Arctic (E22G) mutations. Oligomeric preparations of the mutations exhibited extensive protofibril and fibril formation, respectively, but were not consistently different from wild type A beta-(1-42) in terms of inhibition of neuronal viability. However, fibrillar preparations of the mutants appeared larger and induced significantly more inhibition of neuronal viability than wild type A beta-(1-42) fibril preparations. These data demonstrate that protocols developed to produce oligomeric and fibrillar A beta-(1-42) are useful in distinguishing the structural and functional differences between A beta-(1-42) and A beta-(1-40) and genetic mutations of A beta-(1-42).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, the MOAB-2-based oA42 ELISA detects oligomeric but not monomeric A42 using synthetic preparations characterized previously by our laboratory (data not shown) (47,48).”
From APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease (2012) · cites this paper as [47]
In the citing paper
“The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM (Figure 10, panel a) while the Western blot shows the presence of higher order Aβ42 oligomers (Figure 10, lane a), likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.89–91”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [90]
In the citing paper
“However, this approach may not be optimal for the Aβ42 peptide, given the increased toxicity observed for the soluble Aβ42 oligomers.90”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [90]
In the citing paper
“Finally, in neurons, PCSK9 overexpression led to a worsening of neurotoxicity induced by different aggregation forms of Aβ, which have previously been demonstrated to have toxic effects in these cells [31,52].”
From PCSK9 affects astrocyte cholesterol metabolism and reduces neuron cholesterol supplying in vitro: potential implications in Alzheimer’s disease (2022) · cites this paper as [52]
In the citing paper
“All A preparations used were similar to those characterized previously (24) in that they contain monomers and oligomers of A but do not contain fibrils (see supplemental Fig. 1, A and B).”
From Internalization of β-Amyloid Peptide by Primary Neurons in the Absence of Apolipoprotein E (2007) · cites this paper as [24]
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationNeurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Saudou, F., Finkbeiner, S. M., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,598
Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Cited by
Sorted by citations
Items 701–800 of 1,002
Fully Atomistic Aβ40 and Aβ42 Oligomers in Water: Observation of Porelike Conformations
Voelker, M. J., Barz, B., & Urbanc, B. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00495 · Cited by 33
Interaction between Prion Protein and Aβ Amyloid Fibrils Revisited
Nieznański, K., Surewicz, K. A., Chen, S., Nieznańska, H., & Surewicz, W. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500019c · Cited by 33
Mitochondrial dysfunction and calcium deregulation by the RanBP9‐cofilin pathway
Roh, S., Woo, J. A., Lakshmana, M. K., Uhlar, C., Ankala, V., Boggess, T. C., Liu, T., Hong, Y., Mook‐Jung, I., Kim, S. J., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-234765 · Cited by 33
Zhao, H., Zhu, J., Cui, K., Xu, X., O'Brien, M., Wong, K. K., Kesari, S., Xia, W., & Wong, S. T. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-15 · Cited by 33
Assessing β-Amyloid-Induced NLRP3 Inflammasome Activation in Primary Microglia
Schnaars, M., Beckert, H., & Halle, A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-523-1_1 · Cited by 32
Turn Nucleation Perturbs Amyloid β Self-Assembly and Cytotoxicity
Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.055 · Cited by 32
Rajaram, H., Palanivelu, M. K., Arumugam, T. V., Rao, V. M., Shaw, P. N., McGeary, R. P., & Ross, B. P. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.077 · Cited by 32
Metal attenuating therapies in neurodegenerative disease
Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 32
Mandal, M., & Yan, Z. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058701 · Cited by 30
Pahnke, J., Fröhlich, C., Krohn, M., Schumacher, T., & Paarmann, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.007 · Cited by 35
Lin, T.-W., Chang, C., Chang, Y., Liao, Y., Yu, H., & Chen, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174561 · Cited by 33
Wang, X., Kastanenka, K. V., Arbel‐Ornath, M., Commins, C., Kuzuya, A., Lariviere, A., Krafft, G. A., Hefti, F. F., Jerecìć, J., & Bacskai, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22979-2 · Cited by 32
Zeng, H., Li, P., Zhou, L., & Ding, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.212 · Cited by 32
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
Gutierrez, B. A., & Limón, A. (2022) · Biomedicines · doi:10.3390/biomedicines10071743 · Cited by 32
The Dynamics of CD147 in Alzheimer's Disease Development and Pathology
Kanyenda, L. J., Verdile, G., Boulos, S., Krishnaswamy, S., Taddei, K., Meloni, B. P., Mastaglia, F. L., & Martins, R. N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110584 · Cited by 32
Lindgren, J., Wahlström, A., Danielsson, J., Markova, N., Ekblad, C., Gräslund, A., Abrahmsén, L., Karlström, A. E., & Wärmländer, S. K. T. S. (2010) · Protein Science · doi:10.1002/pro.511 · Cited by 32
Morales, G. G., Huerta‐Reyes, M., González‐Cortazar, M., Zamilpa, A., Jiménez‐Ferrer, E., Silva‐García, R., Román‐Ramos, R., & Aguilar‐Rojas, A. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0587-6 · Cited by 32
Zhou, Y., Jiang, C., Zhang, Y., Liang, Z. T., Liu, W., Wang, L., Luo, C., Zhong, T., Sun, Y. E., Zhao, L., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1000584 · Cited by 32
Sagy‐Bross, C., Hadad, N., & Lévy, R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.09.007 · Cited by 32
Specific Amyloid β Clearance by a Catalytic Antibody Construct
Planque, S. A., Nishiyama, Y., Sonoda, S., Lin, Y., Taguchi, H., Hara, M., Kolodziej, S. J., Mitsuda, Y., González‐Calle, V., Sait, H. B. R., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641738 · Cited by 31
Surface plasmon resonance for the label-free detection of Alzheimer’s β-amyloid peptide aggregation
Palladino, P., Aura, A. M., & Spoto, G. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9172-6 · Cited by 32
Kim, H., Maxwell, J. A., Kong, F.-K., Tang, D.-C. C., & Fukuchi, K.-I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.044 · Cited by 32
Beta-Amyloid-Dependent Expression of NOS2in Neurons: Prevention by an α2-Adrenergic Antagonist
Kalinin, S., Polak, P. E., Madrigal, J. L. M., Gavrilyuk, V., Sharp, A. J., Chauhan, N. B., Marien, M. R., Colpaert, F. C., & Feinstein, D. L. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.873 · Cited by 32
Ramberg, V., Tracy, L. M., Samuelsson, M., Nilsson, L. N. G., & Iverfeldt, K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-34 · Cited by 33
Sagy‐Bross, C., Kasianov, K., Solomonov, Y., Braiman, A., Friedman, A., Hadad, N., & Lévy, R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.13012 · Cited by 31
Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone
Maiti, P., Piacentini, R., Ripoli, C., Grassi, C., & Bitan, G. (2010) · Biochemical Journal · doi:10.1042/bj20101391 · Cited by 31
Moll, L., & Schubert, M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/384094 · Cited by 31
Discovery and characterization of a mammalian amyloid disaggregation activity
Murray, A. N., Solomon, J. P., Wang, Y., Balch, W. E., & Kelly, J. W. (2010) · Protein Science · doi:10.1002/pro.363 · Cited by 31
Scutellarin Mitigates Aβ-Induced Neurotoxicity and Improves Behavior Impairments in AD Mice
Zeng, Y.-Q., Cui, Y.-B., Gu, J.-H., Liang, C., & Zhou, X. (2018) · Molecules · doi:10.3390/molecules23040869 · Cited by 31
Alzheimer’s Disease: Lessons Learned from Amyloidocentric Clinical Trials
Soejitno, A., Tjan, A., & Purwata, T. E. (2015) · CNS Drugs · doi:10.1007/s40263-015-0257-8 · Cited by 32
Härtig, W., Saul, A., Kacza, J., Grosche, J., Goldhammer, S., Michalski, D., & Wirths, O. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12050 · Cited by 30
Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease
Jean, L., Thomas, B., Tahiri‐Alaoui, A., Shaw, M. K., & Vaux, D. J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000652 · Cited by 31
Leclerc, E., Sturchler, E., Vetter, S. W., & Heizmann, C. W. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.2.95 · Cited by 31
Gao, H., Li, C., Nabeka, H., Shimokawa, T., Wang, Z., Cao, Y., & Matsuda, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160093 · Cited by 31
Seed-Induced Heterogeneous Cross-Seeding Self-Assembly of Human and Rat Islet Polypeptides
Hu, R., Ren, B., Zhang, M., Chen, H., Liu, Y., Liu, L., Gong, X., Jiang, B., Ma, J., & Zheng, J. (2017) · ACS Omega · doi:10.1021/acsomega.6b00559 · Cited by 31
Wojcik, S. P., Engel, W. K., McFerrin, J., Paciello, O., & Askanas, V. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.08.009 · Cited by 31
Craft, J. M., Eldik, L. J. V., Zasadzki, M., Hu, W., & Watterson, D. M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:115 · Cited by 31
Qi, W., Zhang, A., Patel, D. A., Lee, S., Harrington, J. L., Zhao, L., Schaefer, D., Good, T. A., & Fernández, E. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21846 · Cited by 31
Amyloid-β fibril formation is not necessarily required for microglial activation by the peptides
Hashioka, S., Monji, A., Ueda, T., Kanba, S., & Nakanishi, H. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.05.001 · Cited by 30
Chen, G.-J., Xiong, Z., & Yan, Z. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-3 · Cited by 30
Aβ inhibits SREBP-2 activation through Akt inhibition
Mohamed, A., Viveiros, A., Williams, K., & Chaves, E. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m076703 · Cited by 35
Trapping and Characterization of Nontoxic Aβ42 Aggregation Intermediates
Foley, A. R., Finn, T. S., Kung, T., Hatami, A., Lee, H., Jia, M., Rolandi, M., & Raskatov, J. A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00340 · Cited by 29
He, Z., Li, X., Han, S., Ren, B., Hu, X., Li, N., Du, X., Ni, J., Yang, X.-G., & Liu, Q. (2021) · Metallomics · doi:10.1093/mtomcs/mfab036 · Cited by 30
Watanabe, T., Iwasaki, K., Ishikane, S., Naitou, T., Yoshimitsu, Y., Yamagata, N., Özdemir, M. B., Takasaki, K., Egashira, N., Mishima, K., et al. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071648 · Cited by 31
Binding of fullerenes to amyloid beta fibrils: size matters
Huy, P. D. Q., & Li, M. S. (2014) · Physical Chemistry Chemical Physics · doi:10.1039/c4cp02348j · Cited by 30
Chen, R.-J., Chang, W.-W., Lin, Y., Cheng, P., & Chen, Y. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400085q · Cited by 30
Amyloid β peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells
Ciaramella, A., Sanarico, N., Bizzoni, F., Moro, M. L., Salani, F., Scapigliati, G., Spalletta, G., Caltagirone, C., & Bossù, P. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.007 · Cited by 29
Amyloid-β E22Δ variant induces synaptic alteration in mouse hippocampal slices
Takuma, H., Teraoka, R., Mori, H., & Tomiyama, T. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3282fb78c4 · Cited by 30
Volpato, D., & Holzgrabe, U. (2018) · Molecules · doi:10.3390/molecules23123230 · Cited by 29
Piacentini, R., Ripoli, C., Leone, L., Misiti, F., Clementi, M. E., D’Ascenzo, M., Giardina, B., Azzena, G. B., & Grassi, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05680.x · Cited by 30
Johnson, R. D., Steel, D. G., & Gafni, A. (2014) · Protein Science · doi:10.1002/pro.2479 · Cited by 29
Brain Aging and Late-Onset Alzheimer’s Disease: A Matter of Increased Amyloid or Reduced Energy?
Mecocci, P., Baroni, M., Senin, U., & Boccardi, V. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179903 · Cited by 30
Perez, C., Miti, T., Hasecke, F., Meisl, G., Hoyer, W., Muschol, M., & Ullah, G. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b02338 · Cited by 29
Trehalose Conjugates of Silybin as Prodrugs for Targeting Toxic Aβ Aggregates
García‐Viñuales, S., Ahmed, R., Sciacca, M. F. M., Lanza, V., Giuffrida, M. L., Zimbone, S., Romanucci, V., Zarrelli, A., Bongiorno, C., Spinella, N., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00232 · Cited by 29
Sanders, H. M., Jovcevski, B., Marty, M. T., & Pukala, T. L. (2021) · FEBS Journal · doi:10.1111/febs.16122 · Cited by 29
Cyclooxygenase-Dependent Lipid-Modification of Brain Proteins
Boutaud, O. G., Andreasson, K. I., Zagol-Ikapitte, I. A., & Oates, J. A. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00510.x · Cited by 29
Dynamics of Metastable β-Hairpin Structures in the Folding Nucleus of Amyloid β-Protein
Cruz, L., Rao, J. S., Teplow, D. B., & Urbanc, B. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp301619v · Cited by 29
Lee, E., Eom, J.-E., Kim, H.-L., Kang, D.-H., Jun, K.-Y., Jung, D. S., & Kwon, Y. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.01.015 · Cited by 28
Polyglutamine aggregates impair lipid membrane integrity and enhance lipid membrane rigidity
Ho, C. S., Khadka, N. K., She, F., Cai, J., & Pan, J. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.01.016 · Cited by 30
Choi, J., Park, H., Oh, M. S., Yoo, H. H., Lee, S., & Ha, S. K. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.02.010 · Cited by 29
Wang, J. S.-H., Whitehead, S. N., & Yeung, K. K. ‐. (2018) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-018-1896-z · Cited by 31
Modeling of the Inhibitory Effect of Nanoparticles on Amyloid β Fibrillation
Ramesh, N. K., Swathi, S., & Mani, E. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b00388 · Cited by 29
Lu, C.-D., Ma, J.-K., Luo, Z.-Y., Tai, Q., Wang, P., & Guan, P.-P. (2018) · Aging · doi:10.18632/aging.101615 · Cited by 29
Targeting Pathological Amyloid Aggregates with Conformation-Sensitive Antibodies
Bigi, A., Loffredo, G., Cascella, R., & Cecchi, C. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201109093848 · Cited by 29
Protein phosphatase 5 protects neurons against amyloid‐β toxicity
Sanchez‐Ortiz, E., Hahm, B. K., Armstrong, D. L., & Rossie, S. S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06337.x · Cited by 29
Geniposide Alleviates Amyloid-Induced Synaptic Injury by Protecting Axonal Mitochondrial Trafficking
Zhang, H., Zhao, C., Lv, C., Liu, X., Du, S., Li, Z., Wang, Y., & Zhang, W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00309 · Cited by 28
Dodge, J. C., Tamsett, T. J., Treleaven, C. M., Taksir, T. V., Piepenhagen, P. A., Sardi, S. P., Cheng, S. H., & Shihabuddin, L. S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00966-0 · Cited by 26
Li, Q., Moreno‐González, I., Xie, Z., Gamez, N., Vegas‐Gomez, L., Song, Q., Gu, J., Lin, W., Gomez‐Gutierrez, R., & Wu, T. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12673 · Cited by 28
Dimeric Transthyretin Variant Assembles into Spherical Neurotoxins
Matsubara, K., Mizuguchi, M., Igarashi, K., Shinohara, Y., Takeuchi, M., Matsuura, A., Saitoh, T., Mori, Y., Shinoda, H., & Kawano, K. (2005) · Biochemistry · doi:10.1021/bi048838c · Cited by 28
TDP-43: A new player on the AD field?
Youmans, K. L., & Wolozin, B. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.018 · Cited by 28
Trojan, E., Tylek, K., Schröder, N., Kahl, I., Brandenburg, L.-O., Mastromarino, M., Leopoldo, M., Basta-Kaim, A., & Lacivita, E. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02543-2 · Cited by 26
Reinke, A. A., Seh, H. Y., & Gestwicki, J. E. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.082 · Cited by 26
Jain, S. K., Stevens, C. M., Margret, J. J., & Levine, S. N. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0245 · Cited by 33
Fonseca‐Gomes, J., Costa-Coelho, T., Ferreira-Manso, M., Inteiro-Oliveira, S., Vaz, S. H., Alemãn-Serrano, N., Atalaia-Barbacena, H., Ribeiro‐Rodrigues, L., Ramalho, R. M., Pinto, R. R., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.08.022 · Cited by 27
Jiang, X., Chen, L.-L., Lan, Z., Xiong, F., Xu, X., Yin, Y.-Y., Li, P., & Wang, P. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02889-z · Cited by 28
Kilinc, D., Vreulx, A.-C., Mendes, T., Flaig, A., Coelho, D. M., Verschoore, M., Demiautte, F., Amouyel, P., Bank, N.-C. B., Eysert, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa139 · Cited by 34
Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer’s disease
Zaretsky, D. V., & Zaretskaia, M. V. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135959 · Cited by 27
Hu, J., Zhang, Q., Meyer‐Baese, A., & Ye, M. (2021) · Applied Mathematical Modelling · doi:10.1016/j.apm.2021.10.004 · Cited by 26
Ashby, E. L., Miners, J. S., Kumar, S., Walter, J., Love, S., & Kehoe, P. G. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12212 · Cited by 26
Role of Small Oligomers on the Amyloidogenic Aggregation Free-Energy Landscape
He, X., Giurleo, J. T., & Talaga, D. S. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.019 · Cited by 26
Biological Tuning of Synthetic Tactics in Solid-Phase Synthesis: Application to Aβ(1−42)
Kim, Y. S., Moss, J. A., & Janda, K. D. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo048922y · Cited by 27
Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C
Johansson, J. (2003) · Swiss Medical Weekly · doi:10.4414/smw.2003.09987 · Cited by 26
Suwanna, N., Thangnipon, W., & Soi‐ampornkul, R. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.029 · Cited by 26
Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and Neurotoxicity
Roychaudhuri, R., Zheng, X., Lomakin, A., Maiti, P., Condron, M. M., Benedek, G. B., Bitan, G., Bowers, M. T., & Teplow, D. B. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00180 · Cited by 26
ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice
Fitz, N. F., Carter, A. Y., Tapias, V., Castranio, E. L., Kodali, R. B., Lefterov, I. M., & Koldamova, R. P. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161056 · Cited by 27
Yue-Qin, Z., Gu, J.-H., Chen, L., Zhang, T., & Zhou, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104324 · Cited by 26
Synchrotron X-ray Fluorescence and FTIR Signatures for Amyloid Fibrillary and Nonfibrillary Plaques
Álvarez-Marimon, E., Castillo-Michel, H. A., Reyes-Herrera, J., Curto, J. S., Aso, E., Carmona, M., Ferrer, I., Cladera, J., & Benseny‐Cases, N. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00048 · Cited by 26
Amyloid Beta Peptides Differentially Affect Hippocampal Theta Rhythms In Vitro
Gutiérrez-Lerma, A. I., Ordaz, B., & Peña‐Ortega, F. (2013) · International Journal of Peptides · doi:10.1155/2013/328140 · Cited by 26
Condron, M. M., Monien, B. H., & Bitan, G. (2008) · The Open Biotechnology Journal · doi:10.2174/1874070700802010087 · Cited by 27
Effects of Tissue Transglutaminase on β -Amyloid1-42-Induced Apoptosis
Wakshlag, J. J., Antonyak, M. A., Boehm, J. E., Boehm, K., & Cerione, R. A. (2006) · The Protein Journal · doi:10.1007/s10930-006-0009-1 · Cited by 26
Härtig, W., Kacza, J., Paulke, B., Grosche, J., Bauer, U. U. I., Hoffmann, A., Elsinghorst, P. W., & Gütschow, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07038.x · Cited by 26
Distinctive roles of different β‐amyloid 42 aggregates in modulation of synaptic functions
Chiang, H., Iijima, K., Hakker, I., & Zhong, Y. (2009) · The FASEB Journal · doi:10.1096/fj.08-121152 · Cited by 25
Monitoring Insulin Aggregation via Capillary Electrophoresis
Pryor, E. N., Kotarek, J. A., Moss, M. A., & Hestekin, C. N. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129369 · Cited by 28
Ning, C., Mo, L., Chen, X., Tu, W., Wu, J., Hou, S., & Xu, J. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.019 · Cited by 26
Amyloid Beta Secreted during Consolidation Prevents Memory Malleability
Finnie, P. S. B., & Nader, K. (2020) · Current Biology · doi:10.1016/j.cub.2020.02.083 · Cited by 30
Szegedi, V., Fülöp, L., Farkas, T., Rózsa, É., Robotka, H., Kis, Z., Penke, Z., Horváth, S., Molnár, Z., Datki, Z., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.008 · Cited by 26
Human Amylin Actions on Rat Cholinergic Basal Forebrain Neurons: Antagonism of Beta-Amyloid Effects
Jhamandas, J. H., Harris, K. H., Cho, C., Fu, W., & MacTavish, D. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01138.2002 · Cited by 26
The Alzheimer’s β amyloid (Aβ1–39) monomer in an implicit solvent
Anand, P., Nandel, F. S., & Hansmann, U. H. E. (2008) · The Journal of Chemical Physics · doi:10.1063/1.2907718 · Cited by 26
PACAP–Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer’s disease
Wang, Q., Wang, Y., Li, S., & Shi, J. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01334-2 · Cited by 25
Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
Declercq, L., Vandenberghe, R. R., Laere, K. V., Verbruggen, A., & Bormans, G. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00088 · Cited by 27
Metadata
- Authors
- Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- LaDu, Mary Jo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 277
- Issue
- 35
- Pages
- 32046-32053
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2168025729
- Cited by
- 1,452
- References
- 71
- Citations by year
- 2026: 25 · 2025: 33 · 2024: 40 · 2023: 46 · 2022: 45 · 2021: 47 · 2020: 49 · 2019: 55 · 2018: 65 · 2017: 58 · 2016: 61 · 2015: 70 · 2014: 78 · 2013: 86 · 2012: 86
- FWCI
- 22.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, amyloid-beta oligomers, amyloid fibrils, Alzheimer's disease, neuronal viability, peptide aggregation, protofibrils, neurotoxicity
- MeSH terms
- Alzheimer Disease, Cell Survival, Humans, Neuroblastoma, Neurons, Peptide Fragments, Tumor Cells, Cultured, Amyloid beta-Peptides, Microscopy, Atomic Force
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review